Smartsheet (SMAR)
(Real Time Quote from BATS)
$47.26 USD
-0.97 (-2.01%)
Updated Jul 30, 2024 03:16 PM ET
2-Buy of 5 2
F Value A Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SMAR 47.26 -0.97(-2.01%)
Will SMAR be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SMAR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SMAR
Smartsheet (SMAR) Soars 5.5%: Is Further Upside Left in the Stock?
Smartsheet (SMAR) Upgraded to Buy: Here's Why
SMAR: What are Zacks experts saying now?
Zacks Private Portfolio Services
CHGG or SMAR: Which Is the Better Value Stock Right Now?
Smartsheet (SMAR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Smartsheet (SMAR) Tops Q1 Earnings and Revenue Estimates
Other News for SMAR
3 Rare Stocks on the Brink of Unprecedented Growth
Monday.Com: Already An Incredible Business, But Still Early Innings Of The Growth Story
Optimist Fund Q2 2024 Quarterly Letter
Amgen, Garmin among relative market leaders poised to outperform in coming months: BTIG
Indices Continue To Follow Through On The Selling